Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 19OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neuroblastoma 2Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Ototoxicity 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, B-Cell 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Graft vs Host Disease 1Esophageal Squamous Cell Carcinoma 1Burkitt Lymphoma 1

Interventions

Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Has announcements × Recurrence × Clear all
NCT03581786 2025-09-02

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

Shanghai Junshi Bioscience Co., Ltd.

Phase 3 Completed
289 enrolled 32 charts 1 FDA

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡